HRTX is Heron Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $0.34. Market cap: $65M. Capital Quality Rank: 40/100 — Stagnant mediocrity.
Stock snapshot
| Price | $0.34 |
| Market cap | $65M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 40 / 100 · Stagnant mediocrity |
| ROIC (TTM) | -1.6% |
| Revenue CAGR (3y) | 12.9% |
| Shareholder buyback yield | -8.55% |
| Altman Z-score zone | Distress |
About HRTX
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Related non-dividend companies
Other non-dividend stocks investors research alongside HRTX. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is HRTX's current stock price?
HRTX (Heron Therapeutics, Inc.) is currently trading at $0.34.
Does HRTX pay a dividend?
HRTX (Heron Therapeutics, Inc.) does not currently pay a regular dividend.
What is HRTX's Capital Quality Rank?
HRTX has a Capital Quality Rank of 40/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track HRTX in DiviDrip
Add HRTX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search HRTX and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.
